The application of tDCS for the treatment of psychiatric diseases

International Review of Psychiatry
Min-Fang KuoMichael A Nitsche

Abstract

Neuroplasticity represents the dynamic structural and functional reorganization of the central nervous system, including its connectivity, due to environmental and internal demands. It is recognized as a major physiological basis for adaption of cognition and behaviour, and, thus, of utmost importance for normal brain function. Cognitive dysfunctions are major symptoms in psychiatric disorders, which are often associated with pathological alteration of neuroplasticity. Transcranial direct current stimulation (tDCS), a recently developed non-invasive brain stimulation technique, is able to induce and modulate cortical plasticity in humans via the application of relatively weak current through the scalp of the head. It has the potential to alter pathological plasticity and restore dysfunctional cognitions in psychiatric diseases. In the last decades, its efficacy to treat psychiatric disorders has been explored increasingly. This review will give an overview of pathological alterations of plasticity in psychiatric diseases, gather clinical studies involving tDCS to ameliorate symptoms, and discuss future directions of application, with an emphasis on optimizing stimulation effects.

References

Apr 9, 1999·Nature Neuroscience·M S Rioult-PedottiJ P Donoghue
Oct 20, 2000·Science·M S Rioult-PedottiJ P Donoghue
Jan 29, 2003·Current Opinion in Pharmacology·Michael SpeddingLaszlo Harsing
Apr 11, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Michael A NitscheWalter Paulus
Nov 11, 1961·Nature·C HEBB
Oct 29, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Michael A NitscheWalter Paulus
May 15, 2004·Cerebral Cortex·Michael A NitscheWalter Paulus
May 19, 2004·The European Journal of Neuroscience·Michael A NitscheFrithjof Tergau
Jun 17, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael A NitscheWalter Paulus
Sep 29, 2004·Neuron·Robert C Malenka, Mark F Bear
Mar 24, 2006·The European Journal of Neuroscience·Michael A NitscheWalter Paulus
Aug 26, 2006·Science·Jonathan R WhitlockMark F Bear
Oct 13, 2006·Psychiatry Research·Paul B FitzgeraldZafiris J Daskalakis
Jan 24, 2007·Biological Psychiatry·Claus NormannMichael Bach
Jan 26, 2007·Journal of Neurophysiology·M A NitscheW Paulus
Mar 14, 2007·International Review of Neurobiology·Yukiori Goto, Anthony A Grace
Jun 8, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shirley FecteauFelipe Fregni
Jun 15, 2007·The International Journal of Neuropsychopharmacology·Paulo S BoggioFelipe Fregni
Jun 27, 2007·Cerebral Cortex·Min-Fang KuoMichael A Nitsche
Nov 16, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shirley FecteauAlvaro Pascual-Leone
Nov 21, 2007·European Psychiatry : the Journal of the Association of European Psychiatrists·Sergio P RigonattiFelipe Fregni
Mar 17, 2009·Journal of Affective Disorders·R FerrucciA Priori
Apr 8, 2009·Experimental Neurology·Michael A NitscheAlvaro Pascual-Leone
May 12, 2009·Biological Psychiatry·Michael A NitscheWalter Paulus
May 15, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Katia Monte-SilvaMichael A Nitsche
Jul 22, 2009·Neuroscience Letters·Paulo Sergio BoggioFelipe Fregni
Aug 13, 2009·The International Journal of Neuropsychopharmacology·Colleen K LooPhilip Mitchell
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George F Koob, Nora D Volkow
Jan 29, 2010·The European Journal of Neuroscience·Paulo Sérgio BoggioFelipe Fregni
Jan 29, 2010·Journal of Neurophysiology·Katia Monte-SilvaMichael A Nitsche
Jun 18, 2010·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Vera MoliadzeWalter Paulus

❮ Previous
Next ❯

Citations

May 20, 2017·International Review of Psychiatry·Irving M Reti
May 7, 2020·Frontiers in Neuroscience·Mayank JogDanny J J Wang
Feb 4, 2021·Journal of Child and Adolescent Psychopharmacology·Saira A WeinzimmerEric A Storch
May 11, 2021·Frontiers in Behavioral Neuroscience·Nadine RittwegerKlaus Funke
Sep 17, 2020·Neuroscience and Biobehavioral Reviews·S M RomanellaE Santarnecchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.